Research and Development

The Research and Development team at Alnylam Pharmaceuticals is dedicated to advancing the discovery and development of innovative RNAi therapeutics. This multidisciplinary team, comprising scientists, engineers, and managers, collaborates on various research initiatives, from early-stage discovery through process development and clinical research, to optimize therapeutic efficacy and safety. Their collective expertise drives the development pipeline, ensuring that cutting-edge RNAi medicines move from concept to market.